Scott T. Tagawa, M.D., MS, FACP Specialties: Medical Oncology, Urological Oncology

Scott T. Tagawa, MD, MS, FACP is a Professor of Medicine and Urology at Weill Cornell Medicine, and an Attending Physician at NewYork-Presbyterian – Weill Cornell Medical Center.

After earning his BS from Georgetown University, Dr. Tagawa received his MD at the University of Southern California School of Medicine. After completing his Internship and Residency training there, he became Chief Resident and subsequently underwent fellowship training in Hematology and Medical Oncology, being appointed Chief Fellow for his final two years. He had the opportunity to train with international leaders in Genitourinary (GU) Oncology. In August 2005, he was appointed Assistant Professor of Medicine at Mount Sinai School of Medicine, serving as Associate Program Director for the Fellowship Training Program. As Director of Genitourinary Oncology for the Division of Hematology and Oncology and Director of Medical Oncology for the Deane Prostate Health and Research Center, Dr. Tagawa took the lead in developing genitourinary clinical trials. He was recruited to Weill Cornell Medical College in 2007. His research covers clinical and translational investigations in genitourinary tumors and thrombosis in malignancy. As the Medical Director of the Genitourinary Oncology Research Program, Dr. Tagawa leads clinical trials in the areas of prostate, kidney, and bladder cancer as well as the prevention and treatment of thrombosis with cancer. He specializes in drug development and theranostics in prostate cancer. Dr. Tagawa also serves as Associate Director of Clinical Research for the Division of Hematology and Medical Oncology, Medical Director of the Cancer Clinical Trials Office of the Meyer Cancer Center, and Chair of the Feasibility Committee for cancer clinical research. Dr. Tagawa is the WCMC principal investigator for the Alliance for Clinical Trials in Oncology (formerly CALGB), serving on the Board of Directors and as a funded member of the Genitourinary Committee. He is a member of the Clinical Practice Guidelines Committee of the American Society of Clinical Oncology (ASCO). Additionally, he serves on the editorial boards of many journals, is a member of numerous national and international medical and scientific societies, and has been named on multiple "top doctor" award lists.

A summary of Dr. Tagawa's Education, Training and/or Faculty Appointments is listed as following:

EDUCATION/TRAINING:

Georgetown University, Washington D.C. B.S.; 1993.

University of Southern California School of Medicine, Los Angeles, CA. M.D.; 1998.

Internship, Internal Medicine. University of Southern California Department of Medicine; June 1998 - June 1999.

Residency, Internal Medicine. University of Southern California Department of Medicine; July 1999 - June 2001.

Chief Resident, University of Southern California Department of Medicine, Los Angeles, CA.; July 2001 -June 2002.

Fellowship, Combined program in Hematology and Oncology. University of Southern California Department of Medicine, Divisions of Hematology and Oncology; July 2002 - June 2005.

Chief Fellow, Hematology; 2003-04.

Chief Fellow, Oncology; 2004-05.

Weill Cornell Graduate School of Medical Sciences, Masters of Science in Clinical Investigation; 2010.

ACADEMIC APPOINTMENTS:

Assistant Professor of Medicine, Division of Hematology & Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, NY; August 2005 - March 2007.

Director, Medical Oncology, Deane Prostate Health & Research Center, Mount Sinai Hospital; August 2005 - March 2007.

Director, Genitourinary Oncology, Division of Hematology & Oncology, Department of Medicine, Mount Sinai School of Medicine; January 2006 - March 2007.

Associate Director, Hematology/Oncology Fellowship Program, Mount Sinai School of Medicine, New York, NY; January 2006 - March 2007.

Assistant Professor of Medicine & Urology, Weill Cornell Medical College, New York, NY; 2007 - 2012.Medical Director, Genitourinary Oncology Research Program; July 2010 – Present.

Associate Professor of Clinical Medicine & Urology, Weill Cornell Medical College, New York, NY; 2013 - 2020.

Richard A Stratton Associate Professor in Hematology and Oncology; 2015 - 2020.

Professor of Medicine & Urology; 2020 - present

HOSPITAL APPOINTMENTS:

Attending Staff Physician, Los Angeles County University of Southern California Medical Center, Los Angeles, CA.; July 2001 - June, 2005.

Assistant Attending Staff Physician, Mount Sinai Medical Center, New York, NY; September 2005 -March 2007.

Assistant Attending Physician, NewYork-Presbyterian Hospital, New York, NY; April 2007 - 2012.

Associate Attending Physician, NewYork-Presbyterian Hospital, New York, NY; 2013 - 2020.

Attending Physician, NewYork-Presbyterian Hospital, New York, NY; 2020 - present

SOCIETY MEMBERSHIPS:

American Society of Clinical Oncology

American Society of Hematology

American College of Physicians

American Urologic Association

Alliance for Clinical Trials in Oncology (formerly CALGB)

American Association for Cancer Research

European Society for Medical Oncology

EDITORIAL BOARDS

Urologic Oncology (Editor, Seminars Section)

Therapeutic Advances in Medical Oncology

Frontiers in Genitourinary Oncology

Annals of Oncology

Journal of Tumor

American Journal of Clinical and Experimental Urology

Ad hoc reviewer:

Journal of Urology

American Journal of Hematology

The Oncologist

Cancer Investigation

OncoTargets and Therapy

European Urology

Cancer

Clinical Cancer Research

International Journal of Cancer

Medical & Surgical Urology

Journal of Clinical Oncology

British Journal of Urology International

Advances in Urology

Lancet Oncology

ASCO-SEP (genitourinary section)

BMC Cancer

Lancet

JAMA Oncology

European Journal of Cancer